Homo sapiens whole: all 31 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)RecruitingNCT06958796Phase 4
- Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive SurgeryRecruitingNCT06617897Phase 3
- IVIG for Infection Prevention After CAR-T-Cell TherapyRecruitingNCT05952804Phase 2
- Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for PreventionRecruitingNCT05764993Phase 2
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin DeficiencyCompletedNCT04722887Phase 1/2Results posted
- Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)TerminatedNCT04547140Phase 2Results posted
- Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac SurgeryTerminatedNCT04244981Phase 4Results posted
- Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary AngioedemaCompletedNCT02584959Phase 3Results posted
- Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve RepairCompletedNCT01809002Phase 3Results posted
- Tolerability and Safety of IGI, 10% With rHuPH20 in PIDDCompletedNCT01485796Phase 2/3Results posted
- Phase 2/3 Study of IGSC, 20% in PIDDCompletedNCT01218438Phase 2/3Results posted
- An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII DeficiencyCompletedNCT00945906Phase 3Results posted
- A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII DeficiencyCompletedNCT00885742Phase 3Results posted
- A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII DeficiencyCompletedNCT00883090Phase 2Results posted
- Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.CompletedNCT00670007Phase 4Results posted
- Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver TransplantationTerminatedNCT00473824Phase 2Results posted
- TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)CompletedNCT00440401Phase 4Results posted
- Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.Status unknownNCT04405518Phase 4
- Prehospital Kcentra for Hemorrhagic ShockActive, not recruitingNCT04019015Phase 2
- CSL Behring Sclero XIIIStatus unknownNCT02551042Phase 2
- Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular SurgeryCompletedNCT01475669Phase 3
- A Clinical Study of Intravenous ImmunoglobulinCompletedNCT00468273Phase 3
- TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)CompletedNCT00293514Phase 3
- Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic RecipientsTerminatedNCT00260234Phase 1/2
- Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C DeficiencyCompletedNCT00157118Phase 2/3
- Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-NeonatesCompletedNCT00066989Phase 2
- Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing FeverCompletedNCT00063089Phase 1/2
- Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)CompletedNCT00002036Phase 1
- The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIVCompletedNCT00001105Phase 1
- A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected ChildrenCompletedNCT00000827Phase 1
- A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)CompletedNCT00000751Phase 3